ARTICLE
3 October 2023

Trade Secret Litigation Soars In The Life Sciences Industry

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Member Thomas Wintner and Associate Nicholas Armington co-authored an article published by IAM on the developing trend of trade secret litigation in the life sciences sector.
United States Intellectual Property

Member Thomas Wintner and Associate Nicholas Armington co-authored an article published by IAM on the developing trend of trade secret litigation in the life sciences sector.

The authors wrote, "The life sciences industry is experiencing a surge in trade secret litigation. While 2016's Defend Trade Secrets Act (DTSA) undeniably contributed to this rise, the full story is more nuanced and implicates trends in the life sciences industry more generally. Multiple factors have contributed to the recent increase in trade secret cases across the US."

SOURCE: IAM

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More